INDIANAPOLIS, May 4, 2021 /PRNewswire/ -- Eli Lilly and
Company (NYSE: LLY) will outline its newly updated Environmental,
Social and Governance (ESG) strategy, highlighting its commitments
in key areas during the company's Sustainability Webcast today at
10:30 am ET. In addition, Lilly has
launched a new comprehensive resource to provide transparency
around the company's ESG goals and progress at esg.lilly.com.
"As Lilly celebrates its 145th anniversary in a moment when
we've all been challenged in unimaginable ways, we are reflecting
on our long history of developing life-changing medicines for
patients and making meaningful contributions to our world.
Sustainability, which flows directly from our purpose and core
values, is integral to everything we do at Lilly and we are keenly
aware that how we work is just as important as what we do," said
David A. Ricks, Lilly Chairman and
Chief Executive Officer. "While this focus is not new, we are
redoubling our efforts—increasing our investment in sustainability,
setting new goals and communicating our progress in new ways to all
of our stakeholders who want to learn more."
Lilly's focus areas for ESG include access and affordability,
diversity and inclusion, community engagement, employee well-being,
human rights, patient safety, climate, waste, water, product
stewardship, corporate governance, business ethics and supply chain
management. Lilly is also adopting standard ESG reporting
frameworks from the Sustainability Accounting Standards Board and
the Taskforce on Climate-Related Financial Disclosures. Highlights
of Lilly's ESG commitments include:
Access and Affordability
- Improving access to quality health care for 30 million people
globally living in limited resource settings annually by 2030
through the Lilly 30x30 initiative
- Implementing solutions to improve accessibility and
affordability in the U.S. for patients who depend on Lilly's
medicines, including steps that make anyone, regardless of
insurance status, eligible to obtain their monthly prescription of
Lilly insulin for $35
Diversity and Inclusion
- Ensuring female representation at Lilly, with women comprising
50% of Lilly's global workforce at the end of 2020 and continuing
to increase the number of women in management roles globally
- Increasing the current representation of Black Americans in
Lilly's U.S. workforce from approximately 10% to 13%
- Doubling the company's annualized spend with African American
suppliers and vendors over the next two years
Racial Justice
- Making a $30 million commitment
to the Unseen Capital Health Fund LP to help support
minority-owned, early-stage health care companies
- Signing the Indy Racial Equity Pledge along with a coalition of
leading corporate and civic organizations across Central Indiana
- Lilly Foundation pledging $25
million and Lilly committing to 25,000 volunteer hours over
five years to combat racial inequality
Environment (by 2030)
- Climate goals enhancing our commitment to renewable electricity
and achieving carbon neutrality
- Waste goals aimed at achieving zero waste to landfill with a
focus on reducing plastic waste and increasing recycling
- Water goals that preserve this precious resource in water
stressed areas and protect our waterways from harmful
discharges
"Lilly has a proud history of sustainability, but today, more
than ever, we believe performance in these areas is central to our
overall success," said Lilly's newly appointed Senior Advisor for
ESG strategy, Jim Greffet. "Greater
transparency is a mandate for all businesses and we are excited to
implement standard ESG frameworks to report on our progress."
More information about Lilly's ESG strategy and progress is
available at esg.lilly.com.
About Eli Lilly and Company
Lilly is a global health care leader that unites caring with
discovery to create medicines that make life better for people
around the world. We were founded more than a century ago by a man
committed to creating high-quality medicines that meet real needs,
and today we remain true to that mission in all our work. Across
the globe, Lilly employees work to discover and bring life-changing
medicines to those who need them, improve the understanding and
management of disease, and give back to communities through
philanthropy and volunteerism. To learn more about Lilly,
please visit us at www.lilly.com and www.lilly.com/news. I-LLY
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking statements (as
that term is defined in the Private Securities Litigation Reform
Act of 1995) about Lilly's ESG efforts, plans, and objectives, and
reflects Lilly's current beliefs and expectations. There can be no
assurance that Lilly will be successful in reaching the goals
discussed above or in its other ESG communications. For additional
information about the factors that could cause actual results to
differ materially from forward-looking statements, see Lilly's Form
10-K and Form 10-Q filings with the United States Securities and
Exchange Commission. Except as required by law, Lilly undertakes no
duty to update forward-looking statements to reflect events after
the date of this release.
Refer to:
|
Molly McCully;
mccully_molly@lilly.com; 317-478-5423 (Media)
|
|
Kevin Hern;
hern_kevin_r@lilly.com; 317-277-1838 (Investors)
|
|
Jim Greffet;
greffet_james_f@lilly.com; 317-277-0032 (ESG)
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/lilly-outlines-robust-plans-to-strengthen-esg-commitments-across-the-globe-301282596.html
SOURCE Eli Lilly and Company